|
Table 6: Comorbidities of study patients. |
|||||
|
Parameter |
Group 1 (N = 84) |
Group 2 (N = 48) |
p* |
||
|
n |
% |
n |
% |
||
|
DM2 |
|||||
|
No Yes |
50 34 |
59.5 40.5 |
30 18 |
62.5 37.5 |
0.73
|
|
HBP |
|||||
|
No Yes |
77 7 |
91.7 8.3 |
43 5 |
89.6 10.4 |
0.68 |
|
Hypertriglyceridemia |
|||||
|
No Yes |
50 34 |
59.5 40.5 |
14 34 |
29.2 70.8 |
0.001 |
|
Hypercholesterolemia |
|||||
|
No Yes |
57 27 |
67.9 32.1 |
32 16 |
66.7 33.3 |
0.88 |
|
HDL-cholesterol (< 50 mg/dl) |
|||||
|
No Yes |
19 65 |
22.6 77.4 |
7 41 |
14.6 85.4 |
0.26 |
|
Dyslipidemia |
|||||
|
No Yes |
41 43 |
48.8 51.2 |
11 37 |
22.9 77.1 |
0.003 |
|
BMI |
|||||
|
Normal weight Overweight Obesity |
14 22 48 |
16.7 26.2 57.1 |
4 10 34 |
8.3 20.8 70.8 |
0.24 |
|
BMI |
|||||
|
< 30 ≥ 30 |
34 50 |
40.5 59.5 |
14 34 |
29.2 70.8 |
0.19 |
|
Abdominal obesity |
|||||
|
No Yes |
15 69 |
17.9 82.1 |
8 40 |
16.7 83.3 |
0.86 |
|
WHR obesity |
|||||
|
No Yes |
17 67 |
20.2 79.8 |
6 42 |
12.5 87.5 |
0.26
|
|
MS |
|||||
|
No Yes |
42 42 |
50.0 50.0 |
17 31 |
35.4 64.6 |
0.1 |
|
* χ2. DM2 = type-2 diabetes mellitus; HBP = high blood pressure; HDL-cholesterol = high-density lipoprotein-cholesterol; BMI = body mass index; WHR = waist-to-hip ratio; MS = metabolic syndrome. Source: archive of the HGZ No. 35, IMSS. |
|||||